RVTY
Revvity Inc.
NYSE: RVTY · HEALTHCARE · DIAGNOSTICS & RESEARCH
$163.48
+7.84% today
Updated 2026-11-03
Market cap
$17.72B
P/E ratio
75.97
P/S ratio
6.08x
EPS (TTM)
$2.09
Dividend yield
0.18%
52W range
$81 – $166
Volume
2.0M
Revvity Inc. (RVTY) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$163.48
12-Month target
$61.88
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.8B | $3.3B | $2.8B | $2.8B | $2.9B | $2.7B | $2.6B | $2.4B | $2.3B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -5.47% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 8.16%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.